Amgen 2007 Annual Report Download - page 106

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
Securities Authorized for Issuance Under Equity Compensation Plans
The following table sets forth certain information as of December 31, 2007 concerning our common stock
that may be issued upon the exercise of options or pursuant to purchases of stock under all of our equity compen-
sation plans approved by stockholders and equity compensation plans not approved by stockholders in effect as
of December 31, 2007:
(a) (b) (c)
Plan Category
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options and Rights
Weighted
Average
Exercise Price
Outstanding
Options and
Rights
Number of
Securities Remaining
Available for Future
Issuance Under
Equity Compensation
Plans (Excluding
Securities Reflected
in Column (a))
Equity compensation plans approved by Amgen security
holders:
Amended and Restated 1991 Equity Incentive Plan ...... 23,023,290 $45.63 24,396,721
Amended and Restated Employee Stock Purchase Plan . . . — $ —(1) 7,254,738
Total Approved Plans ........................... 23,023,290 $45.63 31,651,459
Equity compensation plans not approved by Amgen security
holders: .........................................
Amended and Restated 1993 Equity Incentive Plan(2) ..... 1,729,282 $34.31 —
Amended and Restated 1999 Equity Incentive Plan(2) ..... 13,351,117 $64.70 1,253,189
Amended and Restated 1997 Equity Incentive Plan(3) ..... 2,044,907 $49.29 —
Amended and Restated 1997 Special Non-Officer Equity
Incentive Plan .................................. 26,079,349 $59.09 —
Amended and Restated 1996 Stock Incentive Plan(4) ...... 416,744 $65.77 —
Amended and Restated 1999 Stock Incentive Plan(4) ...... 2,074,350 $61.27 525,803
Amended and Restated Assumed Avidia Equity Plan(5) . . . 57,535 $ 2.00 —
Amended and Restated Assumed Ilypsa, Inc. Stock
Plan(6) ........................................ 11,551 $ 8.29 —
Foreign Affiliate Plans:
Amgen Limited Sharesave Plan ...................... — $ —
(7) 372,839
The Amgen Limited 2000 UK Company Employee Share
Option Plan(8) .................................. — $ — 300,000
The Amgen Technology Ireland Irish Tax Approved Share
Plan(9) ........................................ — $ — 592,168
Total Unapproved Plans .......................... 45,764,835 $59.43 3,043,999
Total All Plans ................................. 68,788,125 $54.81 34,695,458
(1) The purchases occurred on June 30, 2007 and December 31, 2007 (the “Purchase Dates”) with a purchase of
an aggregate 1,362,769 shares of Common Stock at a purchase price of $47.00 per share on June 30, 2007
and 737,231 shares of Common Stock at a purchase price of $39.47 per share on December 31, 2007. Such
purchase prices reflect the lesser of 85% of either the closing price of the Common Stock on the applicable
Purchase Date or the closing price of the Common Stock on the start date of the applicable employee’s par-
ticipation in the plan.
(2) These plans were assumed pursuant to the terms of the merger agreement between Amgen and Immunex
which was approved by our stockholders in May 2002. Both plans were previously approved by Immunex’s
94